EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice

Stephanie Mourad, Abdualrahman Mohammed Abdualkader, Xiaobei Li, Shailee Jani, Rolando B Ceddia, Rami Al Batran iD

Experimental Physiology · 2024-03 · 109 (3) · 350-364

DOI: 10.1113/ep091545 ↗

At a glance

Journal article in Experimental Physiology, published online on 2024-01-09. Written by Stephanie Mourad and 5 co-authors. Institution: Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Insulins, Insulin Resistance. Cited 15 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY 4.0). Funded by: Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), FRQ | Fonds de Recherche du Québec - Santé (FRQS).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Non‐alcoholic fatty liver disease (NAFLD) is projected to be the most common chronic liver disease worldwide and is closely linked to obesity, insulin resistance and type 2 diabetes. Currently, no pharmacological treatments are available to treat NAFLD, and lifestyle modification, including dietary interventions, is the only remedy. Therefore, we conducted a study to determine whether supplementation with medium‐chain triglycerides (MCTs), containing a mixture of C8 and C10 (60/40), attenuates NAFLD in obese and insulin‐resistant mice. To achieve that, we fed C57BL/6 male mice a high‐fat diet (HFD) for 12 weeks to induce obesity and hepatic steatosis, after which obese mice were assigned randomly either to remain on the HFD or to transition to an HFD supplemented with MCTs (HFD + MCTs) or a low‐fat diet (LFD) for 6 weeks as another dietary intervention model. Another group of mice was kept on an LFD throughout the study and used as a lean control group. Obese mice that transitioned to HFD + MCTs exhibited improvement in glucose and insulin tolerance tests, and the latter improvement was independent of changes in adiposity when compared with HFD‐fed mice. Additionally, supplementation with MCTs significantly reduced hepatic steatosis, improved liver enzymes and decreased hepatic expression of inflammation‐related genes to levels similar to those observed in obese mice transitioned to an LFD. Importantly, HFD + MCTs markedly lowered hepatic ceramide and diacylglycerol content and prevented protein kinase C‐ε translocation to the plasma membrane. Our study demonstrated that supplementation with MCTs formulated mainly from C8 and C10 effectively ameliorated NAFLD in obese mice.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2InsulinsInsulin ResistanceMaleAnimalsMiceMice, Inbred C57BLDiet, High-FatDiglyceridesMice, ObeseDietary SupplementsObesityCeramidesLiverTriglycerides

Author keywords

ceramidediacylglycerolhepatic steatosisinflammationmedium-chain triglycerides

Substances

DiglyceridesCeramidesInsulinsTriglycerides

Authors and institutions

  • Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada.
  • Montreal Diabetes Research Center, Montréal, Quebec, Canada.
  • Cardiometabolic Health, Diabetes and Obesity Research Network, Montréal, Quebec, Canada.
  • Muscle Health Research Center, School of Kinesiology and Health Science, York University, North York, Ontario, Canada.

ORCID profiles: Rami Al Batran

Funding

  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Canada Foundation for Innovation (CFI)
  • FRQ | Fonds de Recherche du Québec - Santé (FRQS)
  • New Investigator of the Kidney Research Scientist Core Education and National Training (KRESCENT)

Cite

APA

Mourad, S., Abdualkader, A. M., Li, X., Jani, S., Ceddia, R. B., & Al Batran, R. (2024). A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice. Experimental Physiology, 109(3), 350-364. https://doi.org/10.1113/ep091545

Vancouver

Mourad S, Abdualkader AM, Li X, Jani S, Ceddia RB, Al Batran R. A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice. Experimental Physiology. 2024;109(3):350-364. doi:10.1113/ep091545

BibTeX
@article{Mourad2024,
  author = {Mourad, Stephanie and Abdualkader, Abdualrahman Mohammed and Li, Xiaobei and Jani, Shailee and Ceddia, Rolando B and Al Batran, Rami},
  title = {A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice},
  journal = {Experimental Physiology},
  year = {2024},
  volume = {109},
  number = {3},
  pages = {350--364},
  doi = {10.1113/ep091545}
}
Start for free →